Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes
journal contribution
posted on 2017-04-12, 13:39 authored by Stephanie A. Amiel, Pablo Aschner, Belinda Childs, Philip E. Cryer, Bastiaan E. de Galan, Simon R. Heller, Brian M. Frier, Linda Gonder-Frederick, Timothy Jones, Kamlesh Khunti, Lawrence A. Leiter, Rory J. McCrimmon, Yingying Luo, Elizabeth R. Seaquist, Robert Vigersky, Sophia ZoungasGlucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes
History
Citation
Diabetologia, 2017, 60 (1), pp. 3-6Author affiliation
/Organisation/COLLEGE OF MEDICINE, BIOLOGICAL SCIENCES AND PSYCHOLOGY/School of Medicine/Department of Health SciencesVersion
- VoR (Version of Record)
Published in
DiabetologiaPublisher
Springer Verlagissn
0012-186Xeissn
1432-0428Copyright date
2016Available date
2017-04-12Publisher DOI
Publisher version
http://link.springer.com/article/10.1007/s00125-016-4146-6#Sec1Language
enAdministrator link
Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC